A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients

INTRODUCTION: This study compares the expected occurrence of contraindicated drug–drug interactions (XDDIs) when simeprevir (SIM)- or sofosbuvir (SOF)-containing therapy is added to medication profiles of patients with hepatitis C (HCV) monoinfection to quantify, in relative terms, the population-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Nimish, Nasiri, Mona, Koroglu, Arden, Bliss, Steven, Davis, Melissa, McNutt, Louise-Anne, Miller, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363220/
https://www.ncbi.nlm.nih.gov/pubmed/25708155
http://dx.doi.org/10.1007/s40121-015-0058-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363220/
https://www.ncbi.nlm.nih.gov/pubmed/25708155
http://dx.doi.org/10.1007/s40121-015-0058-x

Ejemplares similares